Loading...

Grifols, S.A.

GIKLY•PNK
Healthcare
Drug Manufacturers - General
$5.74
$0.00(0.00%)
U.S. Market opens in 7h 53m

Grifols, S.A. (GIKLY) Stock Overview

Explore Grifols, S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap15.1B
P/E Ratio16.78
EPS (TTM)$0.35
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$5.33
3 Months$6.99
1 Year Target$7.11

GIKLY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Grifols, S.A. (GIKLY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 31.92, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $7.11.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 16.78 and a market capitalization of 15.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
10.81%
3-Month Change
-13.03%
6-Month Change
-16.20%
Year-to-Date (YTD) Change
-6.82%
1-Year Change
19.58%
3-Year Change
19.58%
5-Year Change
-59.43%
All-Time (Max) Change
45.32%

Contact Information

https://www.grifols.com
34 93 571 02 21
Avinguda de la Generalitat, 152, Barcelona, NaN, 08174

Company Facts

23,833 Employees
IPO DateJan 20, 2010
CountryES
Actively Trading

Frequently Asked Questions